Yield10 Bioscience Inc reports results for the quarter ended in December - Earnings Summary
01/04/2024 22:01
* Yield10 Bioscience Inc YTEN.OQ reported a quarterly
adjusted
loss of 27 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -67 cents. The mean expectation of two analysts
for the quarter was for a loss of 30 cents per share. Wall
Street expected results to range from -31 cents to -30 cents per
share.
* Reported revenue was zero; analysts expected zero.
* Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 27 cents.
* The company reported a quarterly loss of $3.27 million.
* Yield10 Bioscience Inc shares had held steady so far this
quarter and gained 58.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Yield10
Bioscience Inc is $0.50
This summary was machine generated from LSEG data April 1 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.30 -0.27 Beat
Sep. 30 2023 -0.39 -0.41 Missed
Jun. 30 2023 -0.54 -0.64 Missed
Mar. 31 2023 -0.63 -0.76 Missed